FDA May Reclassify ECT Devices
FDA May Reclassify ECT Devices
The FDA may reclassify electroconvulsive therapy devices from class III to class II. The FDA is accepting public comments on the change until March 28.
What is Cranial Electrotherapy Stimulation (CES)?
How to Report Your ECT Injury to the FDA - Life After ECT
Life After ECT Podcast on Spotify
FDA regulates use of two electric shock devices for children's
FDA unjustified in downgrading shock therapy brain injury risks
How to Report Your ECT Injury to the FDA - Life After ECT
Advocacy Update: February 2019
A critique of narrative reviews of the evidence-base for ECT in
10 Facts You May Not Know About Electroconvulsive Therapy (ECT
